Identification of age- and immune-related gene signatures for clinical outcome prediction in lung adenocarcinoma.

Survival differences among patients that were ≤50, 51–70 and >70 years also showed a trend of inverse correlation of age and survival that approached statistical significance ( p = 0.062) (Figure 1A ).

also in 53,322 other papers